202 results on '"Schally, Andrew V."'
Search Results
2. Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity
3. Antagonist of growth hormone-releasing hormone MIA-690 attenuates the progression and inhibits growth of colorectal cancer in mice
4. Effects of growth hormone-releasing hormone agonistic analog MR-409 on insulin-secreting cells under cyclopiazonic acid-induced endoplasmic reticulum stress
5. Growth hormone-releasing hormone antagonistic analog MIA-690 stimulates food intake in mice
6. Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi)
7. Growth hormone-releasing hormone receptor mediates cytokine production in ciliary and iris epithelial cells during LPS-induced ocular inflammation
8. P53, GHRH, inflammation and cancer
9. Experimental therapy of doxorubicin resistant human uveal melanoma with targeted cytotoxic luteinizing hormone-releasing hormone analog (AN-152)
10. A Phase II Trial of AEZS-108 in Castration- and Taxane-Resistant Prostate Cancer
11. The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy
12. Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth
13. Growth hormone-releasing hormone induced transactivation of epidermal growth factor receptor in human triple-negative breast cancer cells
14. Protection of neonatal rat cardiac myocytes against radiation-induced damage with agonists of growth hormone-releasing hormone
15. Endocrine approaches to treatment of Alzheimer's disease and other neurological conditions
16. Bench-to-bedside development of agonists and antagonists of luteinizing hormone–releasing hormone for treatment of advanced prostate cancer
17. Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities
18. THE EFFECTS OF A GROWTH HORMONE-RELEASING HORMONE ANTAGONIST AND A GASTRIN-RELEASING PEPTIDE ANTAGONIST ON INTIMAL HYPERPLASIA OF THE CAROTID ARTERY AFTER BALLOON INJURY IN A DIABETIC RAT MODEL
19. Vasoactive intestinal peptide induces oxidative stress and suppresses metastatic potential in human clear cell renal cell carcinoma
20. Antioxidant activity of vasoactive intestinal peptide in HK2 human renal cells
21. Vasoactive intestinal peptide (VIP) inhibits human renal cell carcinoma proliferation
22. GHRH antagonist inhibits focal adhesion kinase (FAK) and decreases expression of vascular endothelial growth factor (VEGF) in human lung cancer cells in vitro
23. Involvement of neurotransmitters in the action of growth hormone-releasing hormone antagonist on passive avoidance learning
24. Neurotransmitter-mediated action of an antagonist of growth hormone-releasing hormone on anxiolysis in mice
25. Effects of the growth hormone-releasing hormone (GH-RH) antagonist on brain functions in mice
26. Growth hormone-releasing hormone: not only a neurohormone
27. Growth hormone-releasing hormone antagonist induces apoptosis of human endometrial cancer cells through PKCδ-mediated activation of p53/p21
28. Dose escalation and pharmacokinetic study of AEZS-108 (AN-152), an LHRH agonist linked to doxorubicin, in women with LHRH receptor-positive tumors
29. A correlation of endocrine and anticancer effects of some antagonists of GHRH
30. Targeted cytotoxic somatostatin analog AN-162 inhibits growth of human colon carcinomas and increases sensitivity of doxorubicin resistant murine leukemia cells
31. Growth Hormone Releasing Hormone (GHRH) Agonist Improves Cardiac Performance in the Chronic Model of Myocardial Infarction (MI) in Rats
32. GHRH antagonists reduce the invasive and metastatic potential of human cancer cell lines in vitro
33. Inhibition of human non-small cell lung cancers with a targeted cytotoxic somatostatin analog, AN-162
34. Expression and possible implication of growth hormone–releasing hormone receptor splice variant 1 in endometriosis
35. Effects of the LHRH antagonist Cetrorelix on the brain function in mice
36. Vasoactive intestinal peptide (VIP) induces transactivation of EGFR and HER2 in human breast cancer cells
37. New Treatment Approaches for Prostate Cancer Based on Peptide Analogues
38. Expression of growth hormone–releasing hormone receptor splice variant 1 in primary human melanomas
39. Inhibition of human androgen-independent PC-3 and DU-145 prostate cancers by antagonists of bombesin and growth hormone releasing hormone is linked to PKC, MAPK and c-jun intracellular signalling
40. La découverte des hormones hypothalamiques et le développement des analogues antitumoraux
41. Receptors for luteinizing hormone releasing hormone (LHRH) expressed in human non-Hodgkin’s lymphomas can be targeted for therapy with the cytotoxic LHRH analogue AN-207
42. Antagonists of growth hormone releasing hormone and bombesin inhibit the expression of EGF/HER receptor family in H-69 small cell lung carcinoma
43. Effective treatment of experimental human endometrial cancers with targeted cytotoxic luteinizing hormone–releasing hormone analogues AN-152 and AN-207
44. Potent induction of apoptosis in human hepatoma cell lines by targeted cytotoxic somatostatin analogue AN-238
45. Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system
46. Chemotherapy targeted to cancers through tumoral hormone receptors
47. New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin
48. Absence of binding of targeted analogs of somatostatin carrying cytotoxic radicals or radionuclides to growth hormone secretagogue receptors on human myocardium
49. Antitumor effects of the cytotoxic luteinizing hormone–releasing hormone analog AN-152 on human endometrial and ovarian cancers xenografted into nude mice
50. Expression of growth hormone-releasing hormone (GHRH) and splice variants of GHRH receptors in human experimental prostate cancers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.